-
-
Question of the Month
Pharmacy Consulting
Pharmacy Healthcare Solutions LLC (PHSL) consults with pharmaceutical manufacturers, PBMs, pharmacies (retail, specialty, mail service, LTC, and hospital outpatient), and technology companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSL with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.
News & Events
Get Ready: Medicare Model Guidelines Version 9 Are Coming
Medicare Part D coverage for prescription drugs is a federal program that is administered via private entities. Each approved Medicare Part D plan must offer at least a standard level of coverage. The list of covered drugs, or formulary, must include at least 2 drugs in the most commonly prescribed categories and classes. United States Read More →
FDA Novel Drug Approval Trends
Prescription drugs must be approved by the United States Food and Drug Administration (FDA) before entering the market. Each year, the FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) approve a wide range of new drugs and biologics. These products can either be drugs that have never Read More →
PHSL to Attend AMCP Nexus 2023
PHSL President Ann Johnson and Director of Business Development Karlo Zovko will be attending AMCP Nexus 2023 in Orlando, Florida on October 16th-19th. According to AMCP, the conference is expected to attract over 3,000 attendees, and will include 34 education sessions and over 75 exhibitors. To schedule a meeting with Ann and Karlo during the conference, Read More →
Latest from the Blog
Who Assigns Labeler Codes?
Prescription Drug Labeler Code Confusion often arises when evaluating what the labeler code is and who assigns it. When drugs are labeled, the first section of the NDC (National Drug Code) number is classified as the labeler code. Labeler codes are requested by the manufacturer and are required for any manufacturer or distributor who lists Read More →
Medical Devices and Digital Therapeutics: Many Ways to Get to Market
Most people know that for a prescription drug to be on the market, it must receive approval from the United States Food and Drug Administration (FDA). Did you know that many medical devices and Digital Therapeutics (DTx) are also approved and regulated by the FDA? What are medical devices and how are they different from Read More →
New FDA Guidance on the Test-to-Treat COVID-19 Anti-Virals
On December 22, 2021, the Federal Food and Drug Administration (FDA) made news headlines by issuing an emergency use authorization for the use of Pfizer’s ritonavir-boosted nirmatrelvir (Paxlovid) for the treatment of COVID-19. This was followed a day later by the emergency use authorization of Merck’s drug molnupiravir (Lagevrio), also for the treatment of COVID-19. Read More →
Pharmacy Healthcare Solutions LLC (PHSL) consults with pharmaceutical manufacturers, PBMs, pharmacies (retail, specialty, mail service, LTC, and hospital outpatient), and technology companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSL with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.
News & Events
Get Ready: Medicare Model Guidelines Version 9 Are Coming
Medicare Part D coverage for prescription drugs is a federal program that is administered via private entities. Each approved Medicare Part D plan must offer at least a standard level of coverage. The list of covered drugs, or formulary, must include at least 2 drugs in the most commonly prescribed categories and classes. United States Read More →
FDA Novel Drug Approval Trends
Prescription drugs must be approved by the United States Food and Drug Administration (FDA) before entering the market. Each year, the FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) approve a wide range of new drugs and biologics. These products can either be drugs that have never Read More →
PHSL to Attend AMCP Nexus 2023
PHSL President Ann Johnson and Director of Business Development Karlo Zovko will be attending AMCP Nexus 2023 in Orlando, Florida on October 16th-19th. According to AMCP, the conference is expected to attract over 3,000 attendees, and will include 34 education sessions and over 75 exhibitors. To schedule a meeting with Ann and Karlo during the conference, Read More →
Latest from the Blog
Who Assigns Labeler Codes?
Prescription Drug Labeler Code Confusion often arises when evaluating what the labeler code is and who assigns it. When drugs are labeled, the first section of the NDC (National Drug Code) number is classified as the labeler code. Labeler codes are requested by the manufacturer and are required for any manufacturer or distributor who lists Read More →
Medical Devices and Digital Therapeutics: Many Ways to Get to Market
Most people know that for a prescription drug to be on the market, it must receive approval from the United States Food and Drug Administration (FDA). Did you know that many medical devices and Digital Therapeutics (DTx) are also approved and regulated by the FDA? What are medical devices and how are they different from Read More →
New FDA Guidance on the Test-to-Treat COVID-19 Anti-Virals
On December 22, 2021, the Federal Food and Drug Administration (FDA) made news headlines by issuing an emergency use authorization for the use of Pfizer’s ritonavir-boosted nirmatrelvir (Paxlovid) for the treatment of COVID-19. This was followed a day later by the emergency use authorization of Merck’s drug molnupiravir (Lagevrio), also for the treatment of COVID-19. Read More →
Contact
968 Perry Highway
Pittsburgh, PA 15237
Get Directions »
Phone: (412) 635-4650
Follow/Subscribe:
